While far-future dystopian outcomes are frequently posited by opponents of genome editing, these scenarios are of little relevance to practical reproductive medicine. The more interesting question is this: Should we go ahead with genome editing now? I shall argue that the answer is yes, we ought to proceed without undue delay. With current technology (most notably CRISPR), genome editing has the potential to prevent life-threatening genetic diseases. The main arguments commonly raised against going ahead are threefold: 1. Current technology should be used instead of genome editing 2. Genome editing technology is presently too dangerous 3. Allowing genome editing will lead to misuse of the technology. In my view these objections do not amount to strong grounds against genome editing. I shall consider each in turn.